Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Medicine
|
April 14, 2022
A quality improvement initiative to improve the appropriateness of candidemia management by the implementation of a comprehensive candidemia care bundle at a tertiary care hospital in South India: Results of a quasi-experimental study
Merlin Moni, Neeraj Sidharthan, Sangita Sudhir, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapy
Lincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
European Heart Journal. Cardiovascular Imaging
|
June 14, 2023
Multimodality imaging in marantic endocarditis associated with cancer: a multicentric cohort study
François Deharo, Florent Arregle, Yohann Bohbot, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumors
Megan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Nature
|
May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip, Lauren Fairchild, Liping Sun, et al.
Immunity
|
August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
Andrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
European Heart Journal. Acute Cardiovascular Care
|
July 28, 2022
Influence of the healthcare pathway on the outcome of patients with infective endocarditis
Florent Arregle, Nicolas Iline, Roch Giorgi, et al.
Archives of Cardiovascular Diseases
|
May 3, 2021
Infective endocarditis with neurological complications: Delaying cardiac surgery is associated with worse outcome
Florent Arregle, Helene Martel, Mary Philip, et al.
British Journal of Haematology
|
January 1, 2019
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial
Lihua E Budde, David Wu, Daniel B Martin, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fates
Natalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Medicine
|
April 14, 2022
A quality improvement initiative to improve the appropriateness of candidemia management by the implementation of a comprehensive candidemia care bundle at a tertiary care hospital in South India: Results of a quasi-experimental study
Merlin Moni, Neeraj Sidharthan, Sangita Sudhir, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapy
Lincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
European Heart Journal. Cardiovascular Imaging
|
June 14, 2023
Multimodality imaging in marantic endocarditis associated with cancer: a multicentric cohort study
François Deharo, Florent Arregle, Yohann Bohbot, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumors
Megan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Nature
|
May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip, Lauren Fairchild, Liping Sun, et al.
Immunity
|
August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
Andrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
European Heart Journal. Acute Cardiovascular Care
|
July 28, 2022
Influence of the healthcare pathway on the outcome of patients with infective endocarditis
Florent Arregle, Nicolas Iline, Roch Giorgi, et al.
Archives of Cardiovascular Diseases
|
May 3, 2021
Infective endocarditis with neurological complications: Delaying cardiac surgery is associated with worse outcome
Florent Arregle, Helene Martel, Mary Philip, et al.
British Journal of Haematology
|
January 1, 2019
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial
Lihua E Budde, David Wu, Daniel B Martin, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fates
Natalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Page
of 10